Skip to main content

Table 4 Safety information by treatment arm

From: Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial

Treatment

AL, n = 193

ASAQ, n = 188

P-value

Total number of adverse events (AE)

386

346

Mean AEs per patient

2

1.8

0.20

Severity of adverse events (%)

 Mild

83.4

84.7

0.642

 Moderate

13.7

13.9

0.956

 Serious

2.9

1.4

0.382

Relationship of events with the treatment (%)

 Definitely unrelated

29.5

30.3

0.810

 Unlikely

54.2

55.2

0.774

 Possible

12.7

10.7

0.401

 Probable

3.6

3.8

0.926

 Definitely related

0

0